Page 421 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Dermatologic Aspects of Systemic Vasculitis 395

[23] Cupps TR, Fauci AS. The vasculitides. Major Probl. Intern Med. 1981; 21:1-211.
[24] Kluger N, Pagnoux C, Guillevin L; French Vasculitis Study Group. Comparison of

cutaneous manifestations in systemic polyarteritis nodosa and microscopic polyangiitis.
Br. J. Dermatol. 2008; 159:615-620.
[25] Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis: clinical
and laboratory findings in eighty-five patients. Arthritis Rheum. 1999; 42:421-430.
[26] Mahr AD, Neogi T, Merkel PA. Epidemiology of Wegener's granulomatosis: Lessons
from descriptive studies and analyses of genetic and environmental risk determinants.
Clin. Exp. Rheumatol. 2006; 24(2 Suppl 41):S82-S91.
[27] Patten SF, Tomecki KJ. Wegener's granulomatosis: cutaneous and oral mucosal disease.
J. Am. Acad. Dermatol. 1993; 28:710-718.
[28] Comfere NI, Macaron NC, Gibson LE. Cutaneous manifestations of Wegener's
granulomatosis: a clinicopathologic study of 17 patients and correlation to
antineutrophil cytoplasmic antibody status. J. Cutan Pathol. 2007; 34:739-747.
[29] Zycinska K, Wardyn K, Zielonka TM, et al. Cutaneous changes: an initial manifestation
of pulmonary Wegener's granulomatosis. Adv. Exp. Med. Biol. 2013; 755:307-310.
[30] Pagnoux C, Guilpain P, Guillevin L. Churg-Strauss syndrome. Curr. Opin. Rheumatol.
2007; 19:25-32.
[31] Kallenberg CG. Antineutrophil cytoplasmic autoantibody-associated small-vessel
vasculitis. Curr. Opin. Rheumatol. 2007; 19:17-24.
[32] Davis MD, Daoud MS, McEvoy MT, et al. Cutaneous manifestations of Churg-Strauss
syndrome: a clinicopathologic correlation. J. Am. Acad. Dermatol. 1997; 37:199-203.
[33] Chen KR, Ohata Y, Sakurai M, et al. Churg-Strauss syndrome: report of a case without
preexisting asthma. J. Dermatol. 1992; 191:40-47.
[34] Chen KR, Sakamoto M, Ikemoto K, et al. Granulomatous arteritis in cutaneous lesions
of Churg-Strauss syndrome. J. Cutan Pathol. 2007; 34:330-337.
[35] Tancrede-Bohin E, Ochonisky S, Vignon-Pennamen MD, et al. Schonlein-Henoch
purpura in adult patients. Predictive factors for IgA glomerulonephritis in a
retrospective study of 57 cases. Arch. Dermatol. 1997; 133:438-442.
[36] Narchi H. Risk of long term renal impairment and duration of follow up recommended
for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic
review. Arch Dis Child 2005; 90:916-920.
[37] Goldstein AR, White RH, Akuse R, et al. Long-term follow-up of childhood Henoch-
Schonlein nephritis. Lancet 1992; 339:280-282.
[38] Magro CM, Crowson AN. A clinical and histologic study of 37 cases of
immunoglobulin A-associated vasculitis. Am. J. Dermatopathol. 1999; 21:234-240.
[39] Poterucha TJ, Wetter DA, Gibson LE, et al. Histopathology and correlates of systemic
disease in adult Henoch-Schönlein purpura: a retrospective study of microscopic and
clinical findings in 68 patients at Mayo Clinic. J. Am. Acad. Dermatol. 2013; 68:420-
424.
[40] Lhote F, Cohen P, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and
Churg-Strauss syndrome. Lupus 1998; 7:238-258.
[41] Bonsib SM. Polyarteritis nodosa. Semin. Diagn Pathol. 2001; 18:14-23.
[42] Coblyn JS, McCluskey RT. Case records of the Massachusetts General Hospital
[Case 3-2003]. N. Engl. J. Med. 2003; 348:333-342.

Complimentary Contributor Copy